Laura Fugazzola
Overview
Explore the profile of Laura Fugazzola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
166
Citations
3901
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Fugazzola L, Deandrea M, Borgato S, DellAcqua M, Retta F, Mormile A, et al.
Eur Thyroid J
. 2024 Apr;
13(3).
PMID: 38657647
Background: Radiofrequency ablation (RFA) is effective in the treatment of thyroid nodules, leading to a 50-90% reduction with respect to baseline. Current guidelines indicate the need for a benign cytology...
12.
Colombo C, Ceruti D, Succi M, De Leo S, Trevisan M, Moneta C, et al.
Eur Thyroid J
. 2024 Apr;
13(3).
PMID: 38642580
Background: Fatigue is a frequent adverse event during systemic treatments for advanced thyroid cancer, often leading to reduction, interruption, or discontinuation. We were the first group to demonstrate a correlation...
13.
Bischoff L, Ganly I, Fugazzola L, Buczek E, Faquin W, Haugen B, et al.
JAMA Otolaryngol Head Neck Surg
. 2024 Jan;
150(3):265-272.
PMID: 38206595
Importance: Oncocytic (Hürthle cell) thyroid carcinoma is a follicular cell-derived neoplasm that accounts for approximately 5% of all thyroid cancers. Until recently, it was categorized as a follicular thyroid carcinoma,...
14.
Bernardi S, Rosolen V, Barbone F, Borgato S, Deandrea M, De Feo P, et al.
Thyroid
. 2023 Dec;
34(3):360-370.
PMID: 38149599
Thermal ablation (TA) is an established therapeutic option alternative to surgery in patients with solid benign thyroid nodules causing local symptoms. However, a variable part of thyroid nodules remain viable...
15.
De La Fouchardiere C, Fugazzola L, Locati L, Alvarez C, Peeters R, Camacho P, et al.
Endocrine
. 2023 Nov;
83(3):585-593.
PMID: 38001324
Although thyroid cancer (TC) is generally associated with a favourable prognosis, there are certain high-risk groups with a clear unmet therapeutic need. Unravelling the genomic landscape of TC has recently...
16.
De Leo S, DElia S, Grani G, Dondi F, Bertagna F, Puxeddu E, et al.
Thyroid
. 2023 Sep;
33(11):1318-1326.
PMID: 37725571
There is some controversy on the potential relationship between autoimmune processes and clinicopathologic features as well as prognosis of differentiated thyroid cancer (DTC), and the evidence is limited by its...
17.
De Leo S, Trevisan M, Re Sarto G, Moneta C, Pirovano M, Colombo C, et al.
Thyroid
. 2023 Jul;
33(9):1130-1132.
PMID: 37463111
No abstract available.
18.
Cirello V, Lugaresi M, Manzo A, Balla E, Fratianni G, Solari F, et al.
Infection
. 2023 May;
51(4):1079.
PMID: 37170056
No abstract available.
19.
Colombo C, Ceruti D, De Leo S, Bilo G, Trevisan M, Giancola N, et al.
Eur Thyroid J
. 2023 Apr;
12(4).
PMID: 37097040
Background: Hypertension (HTN) is the most frequent adverse event during treatment with lenvatinib (LEN), but data on its best management are limited. Aim: The objective of this study was to...
20.
Cirello V, Lugaresi M, Manzo A, Balla E, Fratianni G, Solari F, et al.
Infection
. 2023 Mar;
51(4):1071-1078.
PMID: 36857020
Purpose: The clinical outcome of COVID-19 disease is worse in males, and the reasons of this gender disparity are currently unclear, though evidences point to a combination of biological and...